Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ATUX ISKAY GROUP LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-15 to 2024-09-14
Current total value of award: $400000
Description: SBIR PHASE I TOPIC #446 - DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT